Metastasis is the leading cause of death among patients with breast cancer. Understanding the role of the extracellular matrix in the metastatic process may lead to the development of improved therapies for cancer patients. Intratumoral hypoxia is found in the majority of breast cancers and is associated with an increased risk of metastasis and patient mortality. Here we demonstrate that hypoxia-inducible factor 1 activates the transcription of genes encoding collagen prolyl hydroxylases that are critical for collagen deposition by breast cancer cells. We show that expression of collagen prolyl hydroxylases promotes cancer cell alignment along collagen fibers, resulting in enhanced invasion and metastasis to lymph nodes and lungs. Lastly, we establish the prognostic significance of collagen prolyl hydroxylase mRNA expression in human breast cancer biopsies, and demonstrate that ethyl 3,4-dihydroxybenzoate, a prolyl hydroxylase inhibitor, decreases tumor fibrosis and metastasis in a mouse model of breast cancer.
Introduction

4
Collagen biogenesis requires collagen prolyl 4-hydroxylases (P4Hs) to catalyze collagen proline hydroxylation. Three isoforms of the P4HA subunit (P4HA1, P4HA2, and P4HA3) form A 2 B 2 tetramers with P4HB resulting in P4H1, P4H2, and P4H3 holoenzymes, respectively (27, 28) . Proper hydroxylation is required for folding newly synthesized procollagen polypeptide chains into stable triple helical molecules, a prerequisite for extracellular secretion (29, 30) .
Following procollagen secretion, peptidases remove N-and C-terminal propeptides, and lysyl oxidase (LOX) cross-links triple-helical molecules to form mature collagen fibers.
Many studies have focused on the role of LOX family members in extracellular collagen crosslinking and tumor progression (9, 18, 31) without considering the rate limiting step of collagen deposition. In this study, we determined that hypoxia-induced collagen prolyl hydroxylase expression promotes collagen deposition enhancing invasion, leading to lymph node and lung metastasis. Elevated P4HA1 and P4HA2 mRNA levels in human breast cancers predict patient mortality. Finally, we demonstrate that treating tumor-bearing mice with ethyl 3,4-dihydroxybenzoate (DHB), a hydroxylase inhibitor, decreases breast cancer fibrosis and metastasis.
Research. 
Orthotopic implantation and metastasis assays
Studies using 7-to-10 week-old female NOD-SCID mice (NCI) were performed according to protocols approved by the Johns Hopkins University Animal Care and Use Committee. Mammary fat pad (MFP) injection, tumor growth measurement, and human genomic DNA extraction from mouse lungs were previously described (8) . Mice were treated with DHB (in 5% ethanol) at 40 mg/kg/day by intraperitoneal injection.
Real-time reverse transcription quantitative PCR (RT-qPCR)
RNA extraction and cDNA synthesis was performed as previously described (8) . The fold change in expression of each target mRNA relative to 18S rRNA was calculated based on the threshold cycle (C t ) as 2 -Δ(ΔCt)
, where ΔC t = C t (target) -C t (18S). For primer sequences, see Supplementary Table S1 .
Fibrillar collagen staining
Tumor sections were stained with 0.1% picrosirius red (Direct Red 80, Sigma) and counterstained with Weigert's hematoxylin to reveal fibrillar collagen. Sections were imaged with an Olympus IX51 fluorescence microscope fitted with an analyzer (U-ANT) and polarizer (U-POT). The percent collagen was quantified by calculating the area of red staining relative to the total area of the tumor section using MetaMorph analysis software.
Hydroxyproline content measurements
Cells were harvested and hydrolyzed in 6N HCl for 16 content was determined by a colorimetric method (32) . The total protein content was measured by the Bradford assay (BioRad).
Immunohistochemistry
Lungs and lymph nodes were fixed in 10% formalin and paraffin embedded. Sections were dewaxed and hydrated. LSAB+ System HRP kit (DAKO) was used for P4HA1, P4HA2, and vimentin staining. HIF-1α staining was performed as described previously (33) . Inflated lung sections were stained with hematoxylin and eosin to visualize metastatic foci.
Statistical analysis
All statistical analysis was performed using GraphPad Prism software. Bonferroni posttests were performed for all ANOVAs. Data from The Cancer Genome Atlas was obtained from http://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp. Survival analysis data was obtained from the Pawitan microarray dataset (35) accessible at NCBI GEO database.
Tumor stiffness measurements
Tumor stiffness measurements were performed using a stepper motor (Harvard Apparatus) with a 1-mm diameter probe perpendicular to a freshly excised and immobilized tumor, with the corresponding force measured using a FlexiForce Load/Force Sensor (Tekscan).
A constant impingement rate was maintained and force was recorded at 300 Hz using ELF software (TekScan). The slope of the indentation depth vs impingement force was used as an effective stiffness measurement.
Results
Inhibition of HIF-1α expression blocks hypoxia-induced P4HA1 and P4HA2 expression
The ECM is a critical factor in the tumor microenvironment (36) (37) (38) . Analysis of MDA-MB-231 breast cancer cells exposed to 20% or 1% O 2 revealed that P4HA1 and P4HA2 mRNA was highly induced under hypoxia ( Supplementary Fig. S1A ). P4HA1 and P4HA2 protein levels were increased within 12 hours and remained elevated for 72 hours of continuous hypoxia ( Supplementary Fig. S1B ). To determine if HIF-1α or HIF-2α was required for P4H expression under hypoxic conditions, we utilized MDA-MB-231 subclones stably transfected with an empty vector (EV) or expression vector(s) encoding shRNA targeting HIF-1α (sh1α), HIF-2α (sh2α), or HIF-1α and HIF-2α (sh1/2α) (8) . Hypoxic induction of P4HA1 and P4HA2 mRNA (Fig.1A) and protein (Fig. 1B) expression was blocked when HIF-1α (but not HIF-2α) was silenced.
Hypoxia-induced P4HA1 and P4HA2 mRNA expression was also blocked by digoxin (inhibits HIF-1α expression) treatment ( Supplementary Fig. S1A ). P4HA1 and P4HA2 were also induced under hypoxic conditions in MCF-7 breast cancer cells and MCF10A immortalized breast epithelial cells (Supplementary Fig. S1C ).
To assess hypoxic induction of collagen hydroxylases in vivo, we injected MDA-MB-231-shEV and -sh1/2α subclones into the mammary fat pad (MFP) of NOD-SCID mice. P4HA protein levels were significantly decreased in tumors derived from sh1/2α as compared to shEV cells ( Fig. 1C and Supplementary Fig. S1D ). Immunohistochemistry of tumor sections showed intense nuclear HIF-1α staining in perinecrotic (hypoxic) regions of the shEV tumors (Fig. 1D) which colocalized with P4HA1 and P4HA2 (Fig. 1D-E 
Collagen prolyl hydroxylase knockdown inhibits breast cancer growth and metastasis
To determine if prolyl hydroxylases are required for metastasis, we generated MDA-MB-231 subclones stably transfected with an empty vector (shLKO.1) or vectors encoding either of two different shRNAs against P4HA1 (shHA1-1 and shHA1-2) or P4HA2 (shHA2-1 and shHA2-2). Immunoblot assays confirmed the knockdown of P4HA1 and P4HA2 ( Fig. 2A ).
Primary tumor growth was attenuated by knockdown of either P4HA1 or P4HA2 ( Fig. 2B and   C ). Differences in cell proliferation were observed in vitro ( Supplementary Fig. S2A ) but were enhanced in vivo where the ECM may play a more important role. More strikingly, the spontaneous lung metastasis was completely abrogated in mice bearing tumors derived from P4HA1 or P4HA2 knockdown cells (Fig. 2D) . Genomic DNA was also isolated from contralateral lungs and quantitative real-time PCR (qPCR) using human-specific primers showed P4HA1 or P4HA2 knockdown reduced metastasis by greater than 99% (Fig. 2E ).
To take into account differences in primary tumor growth rates, we repeated the MFP injection and isolated tumors, lungs, and lymph nodes when primary tumor volumes reached 600 addition, lymphatic metastasis was assessed using human vimentin immunohistochemical staining of ipsilateral axillary lymph nodes (Fig. 2H ). The area of vimentin staining was used to assess breast cancer cell infiltration of mouse lymph nodes. Depletion of either P4HA1 or P4HA2 reduced lymphatic metastasis over 5-fold (Fig. 2I) . Furthermore, the follicular lymph node structure and size were maintained only in the knockdown mice. Immunohistochemical staining for P4HA1 and P4HA2 confirmed expression in the perinecrotic regions of control (shLKO.1) tumors (Fig. 2J ). Residual expression of P4HA1 and P4HA2 in knockdown tumors may reflect incomplete silencing in breast cancer cells, or P4HA expression in host-derived stromal cells, which were not subjected to silencing, or both ( To quantify the extent to which cancer cells contributed to collagen hydroxylase activity, we used primers specific for human, mouse, or human and mouse P4HA1 mRNA. In control (shLKO.1) tumors, human P4HA1 mRNA accounted for 87 ± 5% (mean ± SD) of total RNA whereas mouse P4HA1 mRNA accounted for 9 ± 5% (Supplementary Table S2 ), suggesting the majority of P4HA1 activity originated from the MDA-MB-231 cells.
Collagen hydroxylase knockdown decreases collagen deposition in vitro and in vivo
The hydroxylation of collagen by prolyl hydroxylases is crucial for the folding, stability, and secretion of the collagen triple helix of all fibrillar collagens (30, 40) . We found that secretion of type I collagen was abrogated by the knockdown of HIF-1α, P4HA1, or P4HA2 ( Fig. 3A and B) . We examined the localization of collagen deposition in tumor sections using picrosirius red staining, which detects all fibrillar collagen (including types I, II, III, V, XI, XXIV, and XXVII) when viewed under circularly polarized light (21) . Overall collagen content was greatest in perinecrotic regions ( Fig. 3C and D) , corresponding to sites of highest HIF-1α and P4HA expression (Fig. 1D) . Analysis of control tumors revealed highly aligned collagen fibers in the perinecrotic region of tumors, whereas the bulk of the tumor contained discontinuous, fragmented collagen fibers (Fig. 3D) . The knockdown of P4HA expression in breast cancer cells resulted in a marked decrease in tumor collagen content (both by picrosirius red and Masson trichrome staining) and tumor stiffness in vivo ( Fig. 3E and F and S3C ). We confirmed a reduction in hydroxylase activity by measuring collagen hydroxyproline content in tumor lysates, which correlated with reduced P4HA1/2 mRNA expression ( Fig. 3G and S2H-I ).
Similar results were obtained when we compared tumor sections from control shEV and sh1/2α subclones ( Supplementary Fig. S3A and B), indicating that HIF-1-dependent expression of prolyl hydroxylases promotes collagen deposition in breast tumors. To confirm our results were not cell line specific, we generated MDA-MB-435 subclones ( Supplementary Fig. S4A ). Primary tumor growth and metastasis were similar to the corresponding MDA-MB-231 knockdown cells ( Supplementary Fig. S4B ). Lung metastasis was severely impaired by the P4HA knockdown and correlated with decreased tumor stiffness ( Supplementary Fig. S4C-E) .
Collagen hydroxylase expression promotes cancer cell invasion
Recent studies have shown that straightened and aligned collagen fibers in tumor samples are predictive of patient mortality (41), presumably because collagen fibers provide directional cues that dictate cell morphology and promote cell migration (24, 42) which promotes tissue tension to enhance cancer progression (16, 18) . To determine whether collagen hydroxylase expression by breast cancer cells promotes invasion in vivo we analyzed control and P4HA knockdown tumor margins. Knockdown tumors showed no evidence of invasion into adjacent adipose tissue, whereas all control tumors showed evidence of extensive local invasion (Fig. 4A) .
Since in vitro assays of invasion (such as Boyden chamber assays) do not test the contribution of ECM to invasion, we generated cell-free 3D matrices from confluent cultures of MDA-MB-231 control or P4HA knockdown cells. We seeded naïve MDA-MB-231 cells on these cell-derived matrices and analyzed cell morphology. Compared to cells plated on tissue culture plastic or ECM derived from P4HA knockdown cells, cells seeded on ECM derived from shLKO.1 cells had a spindle-shaped mesenchymal morphology (Fig. 4B) , which is required for cell motility and invasion (42, 43) . To determine if collagen deposited within tumors promotes an invasive cell phenotype, we seeded CMFDA-labeled MDA-MB-231 cells onto control or hydroxylase knockdown tumor sections. Following 24 hours of cell seeding, sections were stained with picrosirius red and imaged for cell-collagen interactions (Fig. 4C) . In control tumors, with abundant collagen content, the MDA-MB-231 cells aligned themselves along collagen fibers with a spindle-shaped morphology. In contrast, the P4HA knockdown tumors did not contain sufficient collagen to promote cell elongation or directionality.
Collagen hydroxylases promote intravasation but not extravasation of breast cancer cells
We hypothesized that reduced cell invasion should result in reduced intravasation. To investigate the contribution of P4HA expression to intravasation, we determined the number of circulating tumor cells (CTCs) following MFP injection. To construct a standard curve, we 
extracted total RNA from 0.5 ml of whole blood from non-tumor-bearing mice mixed with 0, 100, or 400 MDA-MB-231 cells and measured human-specific rRNA levels (Fig. 5A) . Humanspecific rRNA levels in whole blood of tumor-bearing mice were compared to the standard curve to quantify CTCs. P4HA knockdown significantly reduced the number of CTCs (Fig. 5B), suggesting that reduced invasion resulted in decreased intravasation of tumor cells.
To investigate the role of hydroxylase enzymes in pre-metastatic niche formation, we injected shEV-, shLOX-, shP4HA1-, or shP4HA2 subclones and assessed collagen crosslinking in the lung parenchyma (an early step in pre-metastatic niche formation mediated by LOX (9, 31, 44) ). Unlike LOX knockdown, P4HA1 or P4HA2 knockdown had no effect on pre-metastatic niche formation ( Fig. 5C and Supplementary Fig. S5 ). This result is consistent with the role of collagen prolyl hydroxylases as intracellular, non-secreted enzymes as compared to LOX, which is an extracellular enzyme that modifies collagen already present in the ECM.
Next, we assessed extravasation by directly injecting MDA-MB-231 subclones into the tail vein of mice. P4HA knockdown did not affect the ability of cells to extravasate ( Fig. 5D and   E ). However, lung foci comprised of P4HA knockdown cells were smaller (Fig. 5D ) and contained less collagen (Fig. 5F ) than control cell foci. Thus, P4HA knockdown significantly reduces intravasation but does not impair pre-metastatic niche formation or extravasation.
P4HA re-expression in HIF-deficient cells rescues collagen deposition and metastasis
To complement loss-of-function studies, MDA-MB-231-sh1/2α cells were transduced with lentiviral vectors encoding full-length P4HA1 (HA1) or P4HA2 (HA2), or with a control empty vector (EV). MDA-MB-231-sh1/2α+HA1 (or +HA2) cells expressed P4HA levels comparable to MDA-MB-231-EV cells exposed to 1% O 2 ( Supplementary Fig. 6A ). P4HA1 or Fig. 6D-F) , recovered collagen content, and enhanced intravasation ( Supplementary Fig. 6G-I ). P4HA1 and P4HA2 are critical components of the HIFdependent transcriptional response to hypoxia that promotes breast cancer metastasis. P4HA1 or P4HA2 overexpression could not fully compensate for the loss of HIF activity with respect to metastasis, which is consistent with the role of HIFs in the regulation of multiple genes involved in metastasis (8, 9) .
P4HA expression correlates with human breast cancer prognosis
To investigate whether collagen prolyl hydroxylase expression has clinical significance for breast cancer prognosis, we analyzed P4HA1 and P4HA2 gene expression in human breast cancer using the Oncomine database (34) which revealed that P4HA levels were significantly greater in breast cancer tissue than in normal breast tissue (Fig. 6A) . Results from an analysis of Cancer Genome Atlas (http://tcga-data.nci.nih.gov) data were similar (Fig. 6B) . P4HA1 and P4HA2 expression showed highly significant associations with breast cancer stage, was independent of hormone receptor status, but correlated with HER2 expression (Fig. 6C and Supplementary Table S3 ). P4HA1 and P4HA2 mRNA levels (35) were also significantly associated with decreased patient survival (Fig. 6D) . The survival prediction was enhanced by further stratifying patients using both P4HA1 and P4HA2 expression. Thus, expression levels of collagen hydroxylases are prognostic in breast cancer, which is consistent with their essential role in promoting metastasis in the orthotopic transplantation model.
Therapeutic efficacy of collagen prolyl hydroxylase inhibition by DHB
Research. Collagen prolyl hydroxylases are members of a superfamily of dioxygenases that utilize O 2 and α-ketoglutarate as substrates and are competitively inhibited by α-ketoglutarate analogs such as DHB (Fig. 7A) (45) . To evaluate the therapeutic efficacy of inhibiting collagen hydroxylases, we utilized DHB, which inhibits prolyl hydroxylase activity without affecting total protein synthesis or DNA replication (46) . We found that DHB inhibited collagen secretion by cultured MDA-MB-231 cells in a dose dependent manner (Fig. 7B) . Treatment of MDA-MB-231 cells with DHB had a modest inhibitory effect on cell proliferation in vitro ( Supplementary   Fig. S7A ). Next, we established MFP tumors using MDA-MB-231-sh1/2α+HA1 cells to mitigate any confounding effects of DHB on HIF-1α levels (which are negatively regulated by the HIF prolyl hydroxylase PHD2) while maintaining levels of P4HA1. Systemic treatment of mice with 40 mg/kg per day of DHB led to modestly decreased primary tumor growth (Fig. 7C ), but significantly reduced collagen content ( Fig. 7D and E) and lung metastasis ( Fig. 7F and G) without affecting body weight (Supplementary Fig. S7B ). These results suggest that DHB (and possibly other prolyl hydroxylase inhibitors) may provide a novel pharmacological strategy to inhibit metastasis, especially in breast cancer patients with increased levels of P4HA mRNA demonstrable in tumor biopsies.
Discussion
Although several studies have reported increased collagen deposition during breast cancer progression (19, 41, 47) , this is the first study to uncover a molecular mechanism linking intratumoral hypoxia, collagen deposition, and breast cancer invasion and metastasis. We demonstrated that hypoxia-induced HIF-1 transcriptional activity upregulates collagen prolyl hydroxylase expression to dictate tumor collagen content, organization, density, and stiffness in 
Collagen hydroxylases establish a tumor ECM that facilitates metastasis
Collagen content and organization have been shown to promote cancer progression by several mechanisms. Fibrillar collagen content affects the biophysical properties of the ECM (16) (17) (18) . In our study, decreased P4HA expression reduced tumor stiffness and density by reducing the amount of collagen in the ECM. Increased breast cancer stiffness facilitates integrin clustering to promote focal adhesions, which drive invasion (18) . Collagen fiber alignment has been shown to play a critical role in directing the migration of tumor cells in vivo (25) . We found aligned collagen fibers were localized to perinecrotic (hypoxic) regions of tumors. Further, we determined that cancer cells aligned themselves along these fibers, adopting a spindle-shaped morphology. Cancer cells seeded on P4HA knockdown tumor sections, in which collagen deposition was significantly decreased, remained rounded and lacked directionality. While the importance of collagen content in the tumor microenvironment has been well reported (48) , this study is the first to highlight a pathophysiological mechanism (i.e. intratumoral hypoxia) that leads to increased collagen deposition during breast cancer progression. Whereas prior studies have focused on the role of stromal cells, the present study demonstrates that breast cancer cells may also make a critical contribution to ECM remodeling during cancer progression.
Collagen hydroxylases promote intravastion but not extravasation or pre-metastatic niche formation P4HA1 or P4HA2 knockdown prevented cancer cells from invading adjacent fat tissue, decreased the number of circulating tumor cells, and blocked lung metastasis, demonstrating the role of these collagen modifying enzymes in promoting hematogenous dissemination of breast cancer cells to the lungs and possibly other organs. In contrast, P4HA knockdown had no effect on the number of lung foci that formed after direct injection into the tail vein of the mice. Taken together, these data indicate that P4HA1 and P4HA2 play an important role in promoting intravasation by enhancing tissue invasion, whereas they do not affect extravasation. Unlike the secreted enzymes, LOX, LOXL2, and LOXL4, which have been shown to influence metastatic sites by remodeling collagen prior to the arrival of cancer cells (41, 42) , collagen hydroxylases did not affect pre-metastatic niche formation in the lung.
HIF-1 regulates multiple steps in collagen biogenesis
Prior studies focused on the late stages of collagen maturation and crosslinking mediated by the LOX family of extracellular enzymes (9, 31, 44, 49) . The present study highlights the importance of the initial intracellular steps in collagen biogenesis, which control the amount of collagen available for crosslinking. Taken together, HIF-1 affects both early (intracellular) and late (extracellular) steps in collagen fibril formation. This is important because fibrotic breast cancers have the poorest prognosis and highest rate of recurrence (50) and, in mouse models, increased type I collagen is associated with increased tumor growth and lung metastasis (19) . C, tumor volume (mean ± SEM, n = 5, ANOVA) was determined. D-E, tumor sections were stained with picrosirius red and quantified (mean ± SEM, n = 5, Student t test). F, lung sections (3 x 3mm) stained with hematoxylin and eosin G, human genomic DNA content in mouse lungs (mean ± SEM, n = 5, Student's t test). *P < 0.05, **P < 0.01 vs. vehicle treatment. H, hypoxiainduced collagen prolyl hydroxylases expression promotes collagen deposition and breast cancer metastasis.
Research.
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